Impact of maternal thrombocytopenia in pregnancy to neonates

Abstract

Thrombocytopenia in pregnancy is diagnosed based on a platelet count in blood. Nowadays with the prevailing uses of laboratory tests in terms of pregnancy management under National Guideline, early diagnoses of Thrombocytopenia can be done.

Objective: This study aims at evaluating the impact of thrombocytopenia in pregnancy to neonates.

Methods: Prospective descriptive study without a control group.

Results: In 29 cases studied, those early diagnosed were severe thrombocytopenia . The degree of maternal platelet decrements did not correlate with the possibility and the degree of neonatal platelet decrerments. The incident ratio of neonatal thrombocytopenia was 27.58%. For a group of pregnant women whose platelet counts under 100G/l , the incident ratio of neonatal thrombocytopenia was 30.77%. For women above 100G/l, no case of neonatal thrombocytopenia found. The lowest of neonatal platelet count was 58G/l. No neonatal incident of hemorrhageoccurred.

Conclusion: Not all thrombocytopenia cases in pregnancy led to neonatal thrombocytopenia. Only those cases with moderate and severe decrements of platelets could cause neonatal thrombocytopenia. However not all severe cases of platelet decrements led to neonatal thrombocytopenia. There was no correlation between the degrees of maternal and neonatal platelet decrements . Neonatal deaths rarely occurred in terms of severe maternal platelet decrements.